Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04962035
Other study ID # 2006INF
Secondary ID
Status Completed
Phase
First received
Last updated
Start date March 26, 2021
Est. completion date December 22, 2021

Study information

Verified date March 2023
Source Société des Produits Nestlé (SPN)
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This is a follow-up study of a recently completed trial (17.14.INF) evaluating the growth of pre-term infants. Enrolled children will undergo neurocognitive assessments at 18- and 24-months of corrected age (CA).


Description:

This is a follow-up study of a recently completed multi-center, prospective, single-arm, open-label interventional trial (17.14.INF - Alprem RTF: NCT03728764) evaluating the growth of pre-term infants receiving a two-stage PTF feeding system while in the neonatal care unit and continuing until 30 days post-discharge. Enrolled children will undergo neurocognitive assessments at 18- and 24-months of corrected age (CA). The timing of the cognitive assessments aligns with routine check-up visits and reflect the period at which developmental delays may first become evident.


Recruitment information / eligibility

Status Completed
Enrollment 21
Est. completion date December 22, 2021
Est. primary completion date November 30, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 17 Months to 25 Months
Eligibility Inclusion Criteria: 1. Infants / children born prematurely who were enrolled into the original clinical trial and who are less than 24 m of CA. 2. Having obtained his / her parents' (or his or her legally accepted guardian written informed consent and having evidence of personally signed and dated informed consent document indicating that the child's parent(s) / legal guardian has been informed of all pertinent aspects of the study. Exclusion Criteria: 1. Infants identified retrospectively as not meeting the inclusion or exclusion criteria for the original study.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Neurocognitive Follow-up
Standard clinical and parent-reported outcomes on cognitive development, temperament and overall health conditions.

Locations

Country Name City State
Poland Klinika Chorob Dzieci, Uniwersytecki Szpital Dzieciecy Krakow
Slovakia Univerzitna nemocnica Martin Martin
Slovakia Fakultna nemocnica s poliklinikou Nove Zamky Nove Zamky

Sponsors (1)

Lead Sponsor Collaborator
Société des Produits Nestlé (SPN)

Countries where clinical trial is conducted

Poland,  Slovakia, 

Outcome

Type Measure Description Time frame Safety issue
Primary Bayley-III scores at 24 months Bayley Scales of Infant and Toddler Development, third edition (Bayley-III) cognitive score at 24 months of corrected age (CA). Composite scores range 40-160, with a mean of 100 and SD of 10 points. A composite score of 70 or less is an indication of a delay in child neurocognitive development. 24 months of CA
Secondary Bayley-III scores at 18 months Bayley Scales of Infant and Toddler Development, third edition (Bayley-III) cognitive score at 18 months of corrected age (CA). Composite scores range 40-160, with a mean of 100 and SD of 10 points. A composite score of 70 or less is an indication of a delay in child neurocognitive development. 18 months of CA
Secondary Weight Child weight (g) At enrollment, 18 and 24 months of CA
Secondary Length/height Child length/height (cm) At enrollment, 18 and 24 months of CA
Secondary Head circumference Child head circumference (cm) At enrollment, 18 and 24 months of CA
Secondary Child temperament scores Parent-reported child temperament questionnaire validated specifically for children between the ages of 18 and 36 months At 18 and 24 months of CA
Secondary Developmental Milestone scores Parent-reported achievements of specific age-appropriate milestones (yes/no responses to child performing specific milestones or not) At 18 and 24 months of CA
Secondary Number of healthcare usage Retrospective parent-reported recall of the number of healthcare usage and hospitalizations At 18 and 24 months of CA
Secondary Feeding patterns Feeding practice outcomes collected retrospectively at each visit via a parent-reported questionnaire related to breastfeeding duration, prevalence of formula feeding, and age at initiation of complementary feeding At 18 and 24 months of CA
See also
  Status Clinical Trial Phase
Recruiting NCT05527080 - Development of Motility and Cognition in Infants
Recruiting NCT02378246 - Swedish Iodine in Pregnancy and Development in Children (SWIDDICH) Study N/A
Recruiting NCT05201534 - Interventions in Mathematics and Cognitive Skills N/A
Completed NCT03612505 - Caregiver Interventions for Developmental Delays in Young Kenyan Children N/A
Completed NCT04345185 - Effects of Infant Egg Consumption on Child Health and Cognition Development
Completed NCT04252807 - A Common Elements-based Intervention to Improve Maternal Psychological Well-being and Mother-infant Interaction N/A
Completed NCT03552341 - Iodine Status in Pregnancy and Associated Health Outcomes
Completed NCT05217056 - Associations Between General Movements Assessments and Cognitive Development